Enobosarm in AR-positive, ER-positive, and HER2-Negative Advanced Breast Cancer
Physician's Weekly,
1. The clinical benefit rate was 32% in the 9 mg group and 29% in the 18 mg group. 2. Grade 3 or higher treatment-related…
1. The clinical benefit rate was 32% in the 9 mg group and 29% in the 18 mg group. 2. Grade 3 or higher treatment-related…
For decades, hormonal treatment of breast cancer has been going in one direction – blocking estrogen. Now a global study…
Preclinical research from the University of Adelaide (SA, Australia) has given new evidence to suggest that activation of the…
Credit: University of…